Clinical updates, including trial initiations, enrollment status and data readouts and publications: Conformal Medical, Medtronic.

New hires and promotions in the med-tech industry, including: Diagnostix, Saranas.

The top 10 biopharma stock gainers and losers for the week.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Akebia, Astrazeneca, Beigene, Chiesi, Daiichi Sankyo, Incyte, Janssen, Merck, Protalix, Regeneron, Ridgeback, Servier, Sobi, Timber.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Astrazeneca, Biocytogen, Chipscreen, Cincor, Enliven, Essex, Eyepoint, Galapagos, Genescence, Henlius, HRA, Imara, Novartis, Obseva, Perrigo, Pliant, Rallybio, Sinopia.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aslan, Astria, Atea, Biocryst, Codexis, Fulcrum, Innocare, Keymed, Merck, Nektar, Nestlé, Orchard, Oscotec, Prilenia, Regenxbio, Tvardi, Werewolf.

Biopharmas raising money in public or private financings, including: Genprex.

New hires and promotions in the biopharma industry, including: Sensorion.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bio-Techne, Medsource, Olympus, Taewoong, Tactile Systems.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Feops, Sportgait.